On December 1, communities and countries around the world marked World AIDS Day. This annual observance provides an opportunity to raise awareness about the HIV/AIDS epidemic and draws attention to the lifesaving work of HIV health specialists and community workers.
On July 31st, 2020, with support from the USAID HIV/AIDS Flgship (UHF) Project, Myanmar launched its first Pre-Exposure Prophylaxis (PrEP) Program. PrEP is an HIV drug taken by HIV-negative people to protect them against HIV infection. If used consistently and correctly, PrEP virtually eliminates the risk of HIV infection. A number of large trials undertaken across the world have continued to prove PrEP’s effectiveness.
Myanmar Launches HIV Pre-Exposure Prophylaxis Services in Major Milestone for National HIV Prevention
On July 31st, 2020, HIV healthcare providers and other key stakeholders gathered at an event in Yangon to inaugurate Myanmar’s first HIV Pre-Exposure Prophylaxis (PrEP) clinics. This marks a major milestone for Myanmar’s strategic response to HIV, and will contribute to the scaling up of HIV prevention efforts.